<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="features of patients infected with 2019 novel coronavirus in Wuhan," exact="China" post="January 24, 2020 Department of Pulmonary and Critical Care"/>
 <result pre="and Prevention, Beijing, China; School of Public Health, University of" exact="Hong Kong," post="Hong Kong; Hubei Center for Disease Control and Prevention,"/>
 <result pre="Beijing, China; School of Public Health, University of Hong Kong," exact="Hong Kong;" post="Hubei Center for Disease Control and Prevention, Wuhan, Hubei,"/>
 <result pre="30, 2020 Tuberculosis and Respiratory Department, Wuhan Jinyintan Hospital, Wuhan," exact="China" post="7 The New England Journal of Medicine First case"/>
 <result pre="Journal of Medicine First case of 2019 novel coronavirus in" exact="the United States" post="January 31, 2020 The Washington State Department of Health"/>
 <result pre="of Medicine First case of 2019 novel coronavirus in the" exact="United States" post="January 31, 2020 The Washington State Department of Health"/>
 <result pre="Public Health, Li Ka Shing Faculty of Medicine, University of" exact="Hong Kong," post="Hong Kong, Chinab 10 Nature A new coronavirus associated"/>
 <result pre="Li Ka Shing Faculty of Medicine, University of Hong Kong," exact="Hong Kong," post="Chinab 10 Nature A new coronavirus associated with human"/>
 <result pre="Nature A new coronavirus associated with human respiratory disease in" exact="China" post="February 3, 2020 Shanghai Public Health Clinical Center &amp;amp;"/>
 <result pre="138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan," exact="China" post="February 7, 2020 Department of Critical Care Medicine, Zhongnan"/>
 <result pre="Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei," exact="China" post="16 Cell Host &amp;amp; Microbe Genome composition and divergence"/>
 <result pre="composition and divergence of the novel coronavirus (2019-nCoV) originating in" exact="China" post="February 7, 2020 National Institute for Viral Disease Control"/>
 <result pre="7, 2020 National Institute for Viral Disease Control and Prevention," exact="China" post="CDC, Beijing, China; Department of Microbiology, Immunology and Molecular"/>
 <result pre="Basic Medical Sciences, Fudan-Jinbo Joint Research Center, Fudan University, Shanghai," exact="China" post="aNote: The publication date is the date for electronic"/>
 <result pre="currently being studied in phase III clinical trials in both" exact="China" post="and the USA. Favipiravir, a purine nucleoside leading to"/>
 <result pre="studied in phase III clinical trials in both China and" exact="the USA." post="Favipiravir, a purine nucleoside leading to inaccurate viral RNA"/>
 <result pre="endonuclease (CEN) inhibitors and prodrugs thereof Shionogi and Co., Ltd.," exact="Japan" post="US20160122374 20141029 Preparation of nucleosides and methods for treating"/>
 <result pre="USA WO2007075145 20070704 Preparation of benzopyranone derivatives as anti-coronaviral agents" exact="Singapore" post="Polytechnic, Singapore; Shanghai Institute of Materia Medica Chinese Academy"/>
 <result pre="Singapore; Shanghai Institute of Materia Medica Chinese Academy of Sciences," exact="China" post="WO2005021518 20050310 Preparation of 3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid derivatives as cysLT2"/>
 <result pre="antagonists for treatment of respiratory diseases Ono Pharmaceutical Co., Ltd.," exact="Japan" post="WO2007120160 20071025 Preparation of N-heterocyclic acetamides useful for viral"/>
 <result pre="WO2009119167 20091001 Aniline derivative having anti-RNA viral activity KinoPharma, Inc.," exact="Japan" post="WO2013049382 20130404 Broad-spectrum antivirals against 3c or 3c-like proteases"/>
 <result pre="inhibitors: new structures for antivirals and osteoarthritis therapeutics Academia Sinica," exact="Taiwan" post="Patent application WO2013049382 discloses both structures and syntheses of"/>
 <result pre="WO2006051091 spike protein Compositions against SARS-coronavirus and uses thereof Crucell" exact="Holland" post="BV 20041111 WO2006051091 spike protein Compositions against SARS-coronavirus comprising"/>
 <result pre="with non-competing epitopes, and therapeutic and diagnostic uses thereof Crucell" exact="Holland" post="BV 20041111 CN1673231 spike protein Monoclonal antibody of SARS"/>
 <result pre="monoclonal antibodies, and diagnostic, therapeutic and vaccine preparation uses Health" exact="Canada" post="20031205 WO2005060520 spike protein Antibodies specific to SARS-CoV spike"/>
 <result pre="N proteins Antibody binding molecules specific for SARS coronavirus Crucell" exact="Holland" post="BV 20030722 CN1566155 S, N, and M proteins Antibody"/>
 <result pre="vaccine called INO-4800 to be planned for human trials in" exact="the United States" post="in April.57 Protein-Based Vaccines Patent application WO2010063685 by GlaxoSmithKline"/>
 <result pre="called INO-4800 to be planned for human trials in the" exact="United States" post="in April.57 Protein-Based Vaccines Patent application WO2010063685 by GlaxoSmithKline"/>
 <result pre="following a contractual agreement with a Chinese consortium comprised of" exact="China" post="Technology Exchange, Beijing Zhonghua Investment Fund Management, Biology Institute"/>
 <result pre="titers compared to mRNA encoding the S protein S2 subunit." exact="New Zealand" post="white rabbits immunized with MERS-CoV mRNA vaccine encoding the"/>
 <result pre="to be used in the planned Phase 1 study in" exact="the United States." post="Moderna reports that mRNA-1273 is an mRNA vaccine targeting"/>
 <result pre="be used in the planned Phase 1 study in the" exact="United States." post="Moderna reports that mRNA-1273 is an mRNA vaccine targeting"/>
 <result pre="inhibition by the antiviral drug Arbidol. Proc. Natl. Acad. Sci." exact="U. S." post="A.2017, 114 (2), 206–214. 10.1073/pnas.1617020114.28003465 Therapeutic options for the"/>
 <result pre="respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101 (26), 9804–9809. 10.1073/pnas.0403492101.15210961 GlaxoSmithKline press release on"/>
</results>
